Chapter summary
It is impossible to overstate the importance of the endocrine system in regulation of homeostasis, tissue and organ development, and physiological processes in general. The nervous system and endocrine system regulate virtually all physiological functions.
The overlap continues at the mechanism of action for neurotransmitters and hormones. As you have seen, there is a distinct blurring between the actions of a classic hormone traveling in the blood to a target cell compared with growth factors that may act a few microns away from the site of synthesis and secretion on a neighboring cell.Cell signaling
Broadly speaking, hormones influence target cells (those that express receptors capable of binding the hormone) can be divided into those that initially act at the surface of the target cells versus those that act internally. Surface-acting hormones are typically peptides that are too large to pass across the plasma membrane of the target cell. These hormones are often described as having a second messenger mechanism of action. This simply means that the hormone first binds to a membrane receptor, which induces a biochemical change inside the cell that is responsible for the actions attributed to the hormone. Dr. Earl Sutherland (1971 Nobel Prize) was the first to describe the second messenger pathway. He found that for epinephrine to induce liver cells to convert glycogen to glucose, the cells had to trigger an increase in intracellular cyclic AMP. Drs. Martin Rodbell and Alfred Gilman worked out the biochemical steps in detail and were awarded the 1994 Nobel Prize. Surface receptors can be grouped in four classes: seven-transmembrane domain, single-transmembrane, cytokine superfamily, and guanyl cyclase
receptors. In some cases, the receptors when activated (bound by the hormone) become directly enzymatically active (often acting as kinases in which phosphorylation of a cellular protein initiates a cascade of reactions), which is responsible for the hormone effect.
In other cases, hormone binding acts to inhibit or activate enzymes that regulate ion channels or control concentrations of other internal second messenger molecules.For hormones that can enter cells, receptors are typically located in the cell nucleus. In essence many of these hormones, when bound to their receptors, are acting as transcription factors that increase gene activation and subsequently production of mRNA and production of proteins responsible for the observed hormone effects. Generally speaking, such hormones are usually associated with longer or more slowly initiated hormone effects, but there are exceptions.
How effective a given hormone can be is also directly related to the number of receptors available and the concentration of the hormone in the blood or interstitial fluids. Intuitively, all things being equal an increase in the concentration of the hormone correspondingly increases the likelihood that more of the available receptors will be bound and thus it is more likely that a hormone-induced response will occur. This relationship is known as the law of mass action. It is well recognized that there can be dramatic and rapid changes in the concentration of hormones in the blood. For example, after a carbohydrate meal or a glucose challenge, insulin rapidly increases. Other hormones (growth hormone, prolactin, cortisol, etc.) are secreted in acute episodes and/or daily and seasonal rhythms. One of the great break advances in endocrinology occurred in the 1970s when RIAs were developed that were capable of accurately measuring concentrations of many hormones in the blood, milk, saliva and other biological fluids. Prior to this time endocrinologists often relied on cumbersome, much less sensitive bioassays. The RIA depends on the binding of the hormone in question to specific antibodies and the capacity of standards or hormones in unknown samples to compete for these binding sites.
Major hormones
With the advent of molecular and cellular tools, the list of hormones and growth factors seems to expand daily.
However, fundamental physiological functions are linked with a number of well-characterized hormones. The hypophyseal-pituitary axis is at the top of this list. The pituitary gland is composed of three primary parts: pars distalis (anterior pituitary), pars nervosa (posterior pituitary), and pars intermedia (intermediate Iobo of the pituitary). The posterior lobe is fundamentally an extension of hypothalamus with neurosecretory cells that secrete oxytocin and vasopressin. Classically, the anterior lobe contains three classes of epithelial cells: acidophils, basophils, and chromophobes, defined based on their staining characteristics. Use of more sophisticated immunostaining techniques has illustrated that there are classes of cells that secrete growth hormone (GH) and/or Prolactin (Prl), others that secrete gonadotropins (LH and/or FSH) and others that secrete ACTH or TSH. Most of these hormones have some direct effects but also induce the secretion of other important hormones. For example, consider these linkages: GH and IGF-I; FSH and estrogen/testosterone; LH and progesterone/testosterone; TSH and thyroid hormones (T3 and T4). The anterior pituitary hormones are in turn regulated by hypothalamic hormones that are effective because they are secreted directly into the hypophyseal-portal blood that drains directly to the pituitary rather than being diluted in general circulation. Hypothalamic hormones and their corresponding pituitary hormone include thyrotropin-releasing hormone (TRH) and TSH; gonadotropin-releasing hormone (GnRH) and FSH/LH; GH- releasing hormone (GHRH) and GH; GH-inhibiting hormone (GHIH) and GH; corticotropin-releasing hormone (CRH) and ACTC; and prolactin-inhibiting hormone (PIH) and Prl. In addition, secretions of the anterior pituitary hormones are controlled by short, long and long, long loop negative feedback involving hormones produced by the target organs, for example, GNRH—LH/FSH—estrogen/testosterone.The somatomedin hypothesis arose from observations that many of the effects associated with GH seem to be indirect.
It was subsequently learned that many such responses to GH were dependent on IGF-I that is secreted by the liver. IGF-I is structurally very similar to insulin.The fundamental nature of the endocrine pancreas seems to be driven home daily in face of the obesity epidemic in the developed world and increasing prevalence of type II (adult onset diabetes). The pancreatic islets with alpha, beta, and delta cells synthesize and secrete glucagon, insulin, and somatomedin, respectively. Simplistically, diabetes is essentially elevated circulating concentrations of blood glucose that results from either a failure of insulin to be secreted (as normal) in response to increased blood glucose or a failure of insulin to induce the appropriate response (insulin receptor signaling issue,
autoantibodies against insulin, its receptor or beta cells). The classic tests for diabetes include measurement of glucose in urine (usually there should none) and/or the glucose challenge. In this test subjects are either infused (I.V.) with glucose or given an oral bolus of glucose. In normal subjects the peak in blood glucose is blunted and relatively short-lived. With diabetes, the peak concentration is usually higher and the period of elevation longer. The physiological consequences of prolonged elevations in blood glucose can be devastating: vision, circulatory, and metabolic problems (Ingvartsen and Andersen, 2000).
Like the pancreas, the adrenal gland and its hormones are equally critical. The adrenal has two primary regions: cortex and medulla. The medulla essentially functions like postganglionic tissue of the autonomic nervous system, except it secretes epinephrine into the bloodsteam rather than the closely related neurotransmitter norepinephrine. Both the cortex and medulla are key players in the fight-or- flight responses associated with high-stress situations. The adrenal cortex has three distinct zones: glomerulosa, fasciculata, and reticularis. It produced multiple steroid hormones but the two primary ones are aldosterone and corticosteroids (cortisol, corticosterone, etc., depending on the species).
Aldosterone is one of several mineraldocorticoids named for their role in sodium homeostasis. The corticosteroids are also known as glucocorticoids because of the role they play in regulation of glycolysis and gluconeogenesis and maintenance of blood glucose in stressful situations. In animals, monitoring of corticosteroid concentrations in blood, feces, or saliva can be used to evaluate animal wellbeing and particularly stress.The thyroid and its hormones T3 and T4 are closely tied to metabolic rate, tissue development, and general health. T3 is much more biologically potent than T4, and it is now known that several tissues (mammary gland, liver, kidney) have the capacity to deiodinate T4 to produce T3 locally in the tissue. Either hyper or hyposecretion of thyroid hormones can have dramatic metabolic effects in mature animals, and in young animals hyposecretion can markedly retard neural development. The thyroid hormones are secreted by the follicular cells of the thyroid in the Iumenal spaces similar to the mammary alveoli as a part of a larger protein thyroglobulin. When signaled to secrete, the colloid is reabsorbed, the protein is cleaved, and the thyroid hormones are released into circulation. The hormone CT is produced by parafollicular or C cells located in the interstitial regions between the thyroid follicles. It acts in calcium homeostasis by inhibiting bone reabsorption and thus blunts increase in calcium.
The parathyroid glands occur in pairs in each half of the thyroid gland. They are responsible for the secretion of PTH. The primary effect of PTH is to increase blood calcium (bone reabsorption, increase gut uptake).
The list of important and potent growth factors is staggering and growing, but some of the better recognized include atrial natriuretic peptide, EGF, fibroblast growth factor, ghrelin, interleukins, leptin, and transforming growth factors. Moreover, many of the growth factors have many individual members within each class.
For example, more than 30 interleukins are now recognized.The interface between the nervous system and endocrine system to regulate homeostasis and physiological development (reproduction, lactation, growth) becomes ever more intertwined and convoluted with each passing year.
Review questions and answers are available online.
References
Adams, T.E., V.C. Epa, T.P.J. Garrett, and C.W. Ward. 2000. Structure and function of the type 1 insulin-like growth factor receptor. Cell. Mol. Life Sci. 57: 1050-1093.
Ahima, R.S. and J.S. Flier. 2000. Leptin. Annu. Rev. Physiol. 62: 413-437.
Akers, R.M. 2006. Major advances associated with hormones and growth factor regulation of mammary growth and lactation in dairy cows. J. Dairy Sci. 89: 1222-1234.
Akers, R.M. and A.M. Lefcourt. 1982. Teat stimulation- induced prolactin release in non-pregnant and pregnant Holstein heifers. J. Endocrinol. 96: 433-442.
Akers, R.M., D.E. Bauman, A.V. Capuco, G.T. Goodman, and H.A. Tucker. 1981. Prolactin regulation of milk secretion and biochemical differentiation of mammary epithelial cells in periparturient cows. Endocrinology 109: 23-30.
Akers, R.M., T.B. McFadden, S. Purup, M. Vestergaard, K. Sejrsen, and A.V. Capuco. 2000. Local IGF-I axis in peri- pubertal ruminant mammary development. J. Mammary Gland Biol. Neoplasia 5: 43-51.
Akers, R.M., S.E. Ellis, and S.D. Berrya. 2005. Ovarian and IGF-I control of mammary development in prepubertal heifers. Domest. Anim. Endocrinol. 29: 259-267.
Amstalden, M., B.R.C. Alves, S. Liu, R.C. Cardoso, and G.L. Williams. 2011. Neuroendocrine pathways mediating nutritional acceleration of puberty: insight from ruminant models. Front. Endocrinol. (Lausanne) 2: 1-7.
Bauman, D.E. 1999. Bovine somatotropin and lactation: from basic science to commercial application. Domest. Anim. Endocrinol. 17: 101-116.
Berry, S.D.z T.B. McFaddenz R.E. Pearson, and R.M. Akers. 2001. A local increase in the mammary IGF-I: IGFBP-3 ratio mediates the mammogenic effects of estrogen and growth hormone. Domest. Anim. Endocrinol. 21: 39-53.
Berry, S.D., R.D. Howard, PM. Jobst, and R.M. Akers. 2003. Interactions between the ovary and the local IGF-I axis modulate mammary development in prepubertal heifers. J. Endocrinol. 177: 295-304.
Bohrer, B.M., J.M. Kyle, D.D. Boler, PJ. Ricker, MJ. Ritter, and S.N. Carr. 2013. Review: meta-analysis of the effects of ractopamine hydrochloride on carcass cutability and primal cuts of finishing pigs. J. Anim. Sci. 91: 1015-1023.
Butler, A.A., S. Yakar, I.H. Gewolb, M. Karas, Y Okubo, and D. LeRoith. 1998. Insulin-Iike growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comp. Biochem. Physiol. B, Biochem. Mol. Biol. 121: 19-26.
Capper, J.L. and DJ. Hayes. 2012. The environmental and economic impact of removing growth-enhancing technologies from U.S. beef production. J. Anim. Sci. 90: 3527-3537.
Capuco, A.V., J.E. Keys, and JJ. Smith. 1989. Somatotropin increases thryroxine-5'-monodeidonase activity in lactating mammary tissue of the cow. J. Endocrinology 121: 205-211.
Clemmons, D.R. 1998. Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol. Cell. Endocrinol. 140: 19-24.
Clemmons, D.R. and L.A. Made. 2003. Minireview: integral membrane proteins that function coordinately with insulin-like growth factor I receptor to regulate intracellular signaling. Endocrinology 144: 1664-1670.
Cowie, A.T. 1980. Hormonal Control of Lactation. Springer- Verlag, Heidleberg, Berlin.
Cowie, A.T., J.S. Tindal, and A. Yokoyama. 1966. The induction of mammary growth in the hypophysectomized goat. J. Endocrinology 34: 185-195.
Dahl, G.E., B.A. Buchanan, and H.A. Tucker. 2000. Photoperiodic effects on dairy cattle: a review. J. Dairy Sci. 83: 885-893.
Das, R. and B.K. Vonderhaar. 1997. Prolactin as a mitogen in mammary cells. J. Mammary Gland Biology and Neoplasia 1: 331-341.
Denbow, CJ., K.S. Perera, EC. Gwazdauskas, R.M. Akers, R.E. Pearson, and M.L. McGilliard. 1986. Effect of season and stage of lactation on plasma insulin and glucose following glucose injection in Holstein cattle. J. Dairy Sci. 69: 211-216.
Duan, C. 2002. Beyond carrier proteins—specifying the cellular responses to IGF-I signals: roles of IGF-binding proteins. J. Endocrinol. 175: 41-54.
Ellis, S.E., S. Purup, K. Sejrsen, and R.M. Akers. 2000. Growth and morphogenesis of epithelial organoids from peripheral and medial mammary parenchyma of prepubertal heifers. J. Dairy Sci. 83: 952-961.
Etherton, T.D. and D.E. Bauman. 1998. The biology of somatotropin in growth and lactation of domestic animals. Physiol. Rev. 78: 745-761.
Goff, J.P., TA. Reinhardt, and R.L. Horst. 1995. Milk fever and dietary cation-anion balance effects on concentrations of vitamin D receptor in tissues of periparturient dairy cows. J. Dairy Sci. 78: 2388-2394.
Goffin, V. and P. Kelly. 1997. The prolactin/growth hormone receptor family: structure/function relationships. J. Mammary Gland Biol. Neoplasia 2: 7-18.
Good, K.L., DJ. Maggs, S.R. Hollingsworth, R.H. Scagliotti, and R.W. Nelson. 2003. Corneal sensitivity in dogs with diabetes mellitus. Am. J. Vet. Res. 64: 7-11.
Hadsell, D.L. and S.G. Bonnette. 2000. IGF and insulin action in the mammary gland: lessons from transgenic and knockout models. J. Mammary Gland Biol. Neoplasia 5: 19-30.
Hadsell, D.L., S.G. Bonnette, and A.V. Lee. 2002. Genetic manipulation of the IGF-I axis to regulate mammary gland development and function. J. Dairy Sci. 85: 365-377.
Harris, R.C., E. Chung, and RJ. Coffey. 2003. EGF receptor ligands. Exp. Cell Res. 284: 2-13.
Houseknecht, K.L., C. A. Baile, R.L. Matteri, and M.E. Spurlock.
1998. The biology of leptin: a review. J. Anim. Sci. 76: 1405-1420.
Hovey, R.C., TB. McFadden, and R.M. Akers. 1999. Regulation of mammary gland growth and morphogenesis by the mammary fat pad: a species comparison. J. Mammary Gland Biol. Neoplasia 4: 53-68.
Hynes, N.E., N. Celia, and M. Wartmann. 1997. Prolactin mediated intracellular signaling in mammary epithelial cells. J. Mammary Gland Biol. Neoplasia 2: 19-27.
Ignatov, T., H. Eggemann, A. Semczuk, B. Smith, J. Bischoff,
A. Roessner, S.D. Costa, T. Kalinski, and A. Ignatov.
2012. Role of GRP30 in endometrial pathology after tamoxifen for breast cancer. Am. J. Obstet. Gynecol. 203(595): e9-el6.
Ingvartsen, K.L. and J.B. Andersen. 2000. Integration of metabolism and intake regulation: a review focusing on periparturient animals. J. Dairy Sci. 83: 1573-1597.
Koprowski, J.A. and H.A. Tucker. 1973. Bovine serum growth hormone, corticoids and insulin during lactation. Endocrinology 93: 645-651.
Kennedy, G.C. 1953. The role of depot fat in the hypothalamic control of feed intake in the rat. Proc. R. Soc. Lond.,
B, Biol. Sci. 139: 578-592.
Kirsz, K. and D.A. Zieba. 2011. Ghrelin-mediated appetite regulation in the central nervous system. Peptides 32: 2256-2264.
Kleinberg, D.L., M. Feldman, and W. Ruan. 2000. IGF-I is an essential factor in terminal end bud formation and ductal morphogenesis. J. Mammary Gland Biol. Neoplasia 5: 7-19.
Koff, M.D. and K. Plaut. 1995. Detection of transforming growth factor-alpha like messenger RNA in the bovine mammary gland. J. Dairy Sci. 78: 1903-1908.
Kurakula, K., A.A.J. Hamers, V deWaard, and C.J.M. de Vries.
2013. Nuclear receptors in atherosclerosis: a superfamily with many "Goodfellas". Mol. Cell. Endocrinol. 368: 71-84.
Lamb, G.C., C.R. Dahlen, J.E. Larson, G. Marquezini, and J.S. Stevenson. 2010. Control of the estrus cycle to improve fertility for fixed-time artificial insemination in beef cattle: A review. J. Anim. Sci. 88(E. Suppl.): E181-E192.
Lefcourt, A.M. and R.M. Akers. 1983. Is oxytocin really necessary for efficient milk removal in dairy cows? J. Dairy Sci. 66: 2251-2259.
Lefcourt, A.M., J. Bitman, D.L. Wood, and R.M. Akers. 1995. Circadian and ultradian rhythms of peripheral growth hormone concentrations in lactating dairy cows. Domest. Anim. Endocrinol. 12: 247-256.
LeRoithz D. and C.T. Roberts Jr. 2003. The insulin-like growth factor system in cancer. Cancer Lett. 195: 127-137.
Levin, E.R. 2011. Minireview: extranuclear steroid receptors: roles in modulation of cell functions. Mol. Endocrinol. 25: 377-384.
Lyons, W.R., C.H. Li, and R.E. Johnson. 1958. The hormonal control of mammary growth. Recent Prog. Horm. Res. 14: 219-254.
Mann, G.B., KJ. Fowler, A. Gabriel, E.C. Nice, R.L. Williams, and A.R. Dtmn. 1993. Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 73: 249-261.
Martin, K.L., R.M. Hoffman, D.S. Kronfeld, W.B. Ley, and L.D. Warnick. 1996. Calcuim decreases and parathyroid hormone increases in serum of periparturient mares. J. Anim. Sci. 74: 834-839.
Monget, P., S. Fabre, P. Mulsant, F. Lecerf, J. Eisen, S. Mazer- bourg, C. Pisselet, and D. Monniaux. 2002. Regulation of ovarian folliculogenesis by IGF and BMP system in domestic animals. Domest. Anim. Endocrinol. 23: 139-154.
Moustakas, A., S. Souchelnytksyi, and C. Heldin. 2003. Smad regulation in TGF-β signal transduction. J. Cell Sci. 114: 4359-4369.
Mδstl, E. and R. Palme. 2002. Hormones as indicators of stress. Domest. Anim. Endocrinol. 23: 67-74.
Nagpal, R., P. Behare, R. Rana, A. Kumar, M. Kumar, S. Arora, F. Morotta, S. Jain, and H. Yadav. 2011. Bioactive peptides derived from milk proteins and their health beneficial potentials: an update. Food Function 2: 18-27.
Nandi, S. 1958. Endocrine control of mammary development and function in the C3H∕He Crgl mouse. J. Natl. Cancer Inst. 21: 1039-1360.
Nostrand, S.D., D.M. Galton, H.N. Erb, and D.E. Bauman. 1991. Effects of daily exogenous oxytocin on lactation milk yield and composition. J. Dairy Sci. 74: 2119-2127.
Palme, R., C. Robia, C.S. MeBmann, SJ. Hofer, and E. Mostle.
1999. Measurement of faecal cortisol metabolites in ruminants: a non-invasive parameter of adrenocortical function. Wien. TierarztL Monatsschr. 86: 237-241.
Perera, K.S., F.C. Gwazdauskas, R.M. Akers, and R.E. Pearson. 1985. Season and lactational effects on response to thyrotropin releasing hormone injecting in Holstein cows. Domest. Anim. Endocrinol. 2: 43-52.
Peters, R.R., L.T. Chapin, K.B. Leining, and H.A. Tucker. 1978. Supplemental lighting stimulates growth and lactation in cattle. Science 199: 911-912.
Pinilla, L., E. Aguilar, C. Dieguez, R.P. Millar, and M. Tena- Sempere. 2012. Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol. Rev. 92: 1235-1316.
Plaut, K. 1993. The role of epidermal growth factor and transforming growth factors in mammary development and lactation. J. Dairy Sci. 76: 1526-1538.
Plaut, K., AJ. Dean, T.A. Patnode, and T.M. Casey. 2003. Effect of transforming growth factor-beta (TGF-β) on mammary development. J. Dairy Sci. 86(E. Suppl.): E16-E27.
Powers, CJ., S.W. McLeskey, and A. Wellstein. 2000. Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer 7: 165-197.
Romagnolo, D., R.M. Akers, J.C. Byatt, E.A. Wong, and J.D. Turner. 1994. IGF-Linduced IGFBP-3 potentiates the mitogenic actions of IGF-I in mammary epithelial MD-IGF-I cells. Mol. Cell. Endocrinol. 102: 131-139.
Sheffield, L.G. 1998. Hormonal regulation of epidermal growth factor receptor content and signaling in bovine mammary tissue. Endocrinology 139: 4568—4575.
Smith, DJ. 1998. The pharmacokinetics, metabolism, and tissue residues of β-adrenergic agonists in livestock.
J. Anim. Sci. 76: 173-194.
Smith, J.L. and L.G. Sheffield. 2002. Production and regulation of leptin in bovine mammary epithelial cells. Domest. Anim. Endocrinol. 22: 145-154.
Smith, JJ., A.V. Capuco, I.H. Mather, and B.K. Vonderhaar. 1993. Ruminants express a prolactin receptor of M (r) 33,000-36,000 in the mammary gland throughout pregnancy and lactation. J. Endocrinology 139: 37—49.
Stephany, R.W. 2010. Hormonal growth promoting agents in food producing animals. Handb. Exp. Pharmacol. 195: 355-367.
Stern, D.F. 2003. ErbBs in mammary development. Exp. Cell Res. 284: 89-98.
Stricker, P. and R. Grueter. 1928. Action du lobe anterieur de Thypophyse sur la montee Iaiteuse. CR Soc. Biol. (Paris) 99: 1978-1980.
Weber, M.S., P.L. Boyle, B.A. Corl, E.A. Wong, F.C. Gwaz- dauskas, and R.M. Akers. 1998. Expression of ovine insulin-like growth factor-I (IGF-I) stimulates peripuber- tal development of alveolar buds in mammary glands of transgenic mice. Endocrine 8: 251-259.
Weber, M.S., S. Purup, M. Vestergaard, R.M. Akers, and
K. Sejrsen. 2000. Regulation of local synthesis of insulinlike growth factor-I and binding proteins in mammary tissue. J. Dairy Sci. 83: 30-37.
Williams, G.L., M. Amstalden, M.R. Garcia, R.L. Stanko, S.E. Nizelski, C.D. Morrison, and D.H. Keisler. 2002. Leptin and its role in the central regulation of reproduction in cattle. Domest. Anim. Endocrinol. 23: 339-249.
Wiltbank, M.C., R. Sartori, M.M. Herlihy, J.L.M. Vasconcelos, A.B. Nascimento, A.H. Souza, H. Ayres, A.P Cunha, A. Keskin, J.N. Guenther, and A. Gumen. 2011. Managing the dominant follicle in lactating dairy cows. Theriogenol- ogy 76: 1568-1582.
More on the topic Chapter summary:
- CHAPTER SUMMARY
- CHAPTER SUMMARY
- CHAPTER SUMMARY
- CHAPTER SUMMARY
- CHAPTER SUMMARY
- CHAPTER SUMMARY
- Chapter Summary
- CHAPTER SUMMARY
- CHAPTER SUMMARY
- CHAPTER SUMMARY